Chlorpromazine reduces toxicity and Ca2+ uptake induced by amyloid β protein (25-35) in vitro

Brain Research

Volumn 748, Issue 1-2, 1997, Pages 184-188

  Ueda, Keiichi ^a   Yagami, Tatsurou ^a   Asakura, Kenji ^a   Kawasaki, Kazuo ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Alzheimer's disease; amyloid protein; Ca2+ uptake; chlorpromazine; cortical neuron; neurotoxicity; PC12 cell; phenothiazine

Indexed keywords

AMYLOID BETA PROTEIN; CHLORPROMAZINE; NIMODIPINE; PROMETHAZINE; TRIFLUOPERAZINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CALCIUM TRANSPORT; CELL CULTURE; CONTROLLED STUDY; NEUROTOXICITY; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CHLORPROMAZINE; NEURONS; PC12 CELLS; PEPTIDE FRAGMENTS; PHENOTHIAZINES; RATS;

EID: 0031059651     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01300-5     Document Type: Article

References (35)

1. Behl, C., Davis, J.B., Lesley, R. and Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77 (1994) 817-827.
2. Breugnot, C., Maziere, C., Salmon, S., Auclair, M., Santus, R., Morliere, P., Lenaers, A. and Maziere, J.C., Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein, Biochem. Pharmacol., 40 (1990) 1975-1980.
3. Butterfield, D.A., Hensley, K., Harris, M., Mattson, M.P. and Carney, J., β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease, Biochem. Biophys. Res. Commun., 200 (1994) 710-715.
4. Chien, K.R., Abrams, J., Pfau, R.G. and Farber, J.L., Prevention by chlorpromazine of ischemic liver cell death, Am. J. Pathol., 88 (1977) 539-558.
5. Davidson, R.M., Shajenko, L. and Donta, T.S., Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells, Brain Res., 643 (1994) 324-327.
6. Dobyan, D.C. and Bulger, R.E., Partial protection by chlorpromazine in mercuric-chloride-induced acute renal failure in rats, Lab. Invest., 50 (1985) 578-586.
7. Flaim, S.F., Brannan, M.D., Swigart, S.C. and Gleason, M.M., Neuroleptic drugs attenuate calcium influx and tension development in rabbit thoracic aorta: Effects of pimozine, penfluridol, chlorpromazine, and haloperidol, Proc. Natl. Acad. Sci. USA, 82 (1985) 1237-1241.
8. Glenner, G.G. and Wong, C.W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120 (1989) 885-890.
9. Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericak-Vance, M., Roses, A., Williamson, R., Rossor, M., Owen, M. and Hardy, J., Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature, 349 (1991) 704-706.
10. Goodman, Y. and Mattson, M.P., Secreted forms of β- amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury, Exp. Neurol., 128 (1994) 1-12.
11. Goodman, Y. and Mattson, M.P., Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β- peptide toxicity and oxidative injury, Brain Res., 650 (1994) 170-174.
12. Goodman, Y., Steiner, M.R., Steiner, S.M. and Mattson, M.P., Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation, Brain Res., 654 (1994) 171-176.
13. Harris, M.E., Hensley, K., Butterfield, D.A., Leedle, R.A. and Carney, J.M., Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40) in cultured hippocampal neurons, Exp. Neurol., 131 (1995) 193-202.
14. Hendriks, L., van Duijn, C.M., Cras, P., Cruts, M., van Hul, W., van Harskamp, F., Warren, A., McInnis, M.G., Antonarakis, S.E., Martin, J.J., Hofman, A. and van Broeckhoven, C., Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene, Nature Genet., 1 (1992) 218-221.
15. 2+ channels by two mechanisms, Brain Res., 702 (1996) 207-212.
16. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I. and Rydel, R.E., β-amyloid peptide destabilized calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12 (1992) 376-389.
17. Mattson, M.P., Tomaselli, K.J. and Rydel, R.E., Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF, Brain Res., 621 (1993) 35-49.
18. Mullan, M., Crawford, F., Axelman, K., Houden, H., Lilius, L., Winblad, B. and Lannfelt, L., A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N- terminus of β-amyloid, Nature Genet., 1 (1992) 345-347.
19. Murrell, J., Farlow, M., Ghetti, B. and Benson, M.D., A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease, Science, 254 (1991) 97-99.
20. 14C-tyrosine, Pharmacol. Ther. B., 2 (1976) 49-63.
21. Ogata, N. and Narahashi, T., Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells, J. Pharmacol. Exp. Ther., 252 (1990) 1142-1149.
22. Pike, C.J., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res., 563 (1991) 279-282.
23. Rankin, G.O., Valentovic, M.A., Teets, V.J., Nicoll, D.W., Sutherland, C.H. and Brown, P.I., Effect of calcium antagonism by nifedipine and chlorpromazine on acute N-(3,5-dichlorophenyl) succinimide-induced nephrotoxicity in Fischer 344 rats, Toxicology, 66 (1991) 19-34.
24. Sah, D.W.Y. and Bean, B.P., Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists, Mol. Pharmacol., 45 (1994) 84-92.
25. Saville, J.G., Davidson, C.P., D'Adrea, G.H., Born, C.K. and Hamrick, M.E., Inhibition of acetaminophen hepatotoxicity by chlorpromazine in fed and fasted mice, Biochem. Pharmacol., 37 (1988) 2467-2471.
26. Seeman, P., Brain dopamine receptors, Pharmacol. Rev., 32 (1981) 229-313.
27. Selkoe, D.J., Biochemistry of altered brain proteins in Alzheimer's disease, Annu. Rev. Neurosci., 12 (1989) 463-490.
28. Shearman, M.S., Ragan, C.I. and Iversen L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc. Natl. Acad. Sci. USA, 91 (1994) 1470-1474.
29. Simmons, L.K., May, P.C., Tomaselli, K.J., Rydel, R.E., Fuson, K.S., Brigham, E.F., Wright, S., Lieberburg, I., Becker, G.W., Brems, D.N. and Li, W.Y., Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45 (1994) 373-379.
30. Takashima, A., Noguchi, K., Sato, K., Hoshino, T. and Imahori, K., tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity, Proc. Natl. Acad. Sci. USA, 90 (1993) 7789-7793.
31. Ueda, K., Fukui, Y. and Kageyama, H., Amyloid β protein-induced neuronal cell death: neurotoxic properties of aggregated amyloid β protein, Brain Res., 639 (1994) 240-244.
32. Ueda, K., Fukui, Y. and Kageyama, H., Compromise of mitochondrial function induced by amyloid β protein in PC12 cells and protection by cyclic AMP-dependent protein kinase inhibitors, Neurosci. Res. Commun., 15 (1994) 195-200.
33. Ueda, K., Yagami, T., Kageyama, H. and Kawasaki, K., Protein kinase inhibitor attenuates apoptotic cell death induced by amyloid β protein in culture of the rat cerebral cortex, Neurosci. Lett., 203 (1996) 175-178.
34. 2+ channel blockers Attenuate β-amyloid peptide toxicity to cortical neurons in culture, J. Neurochem., 62 (1994) 372-375.
35. Yankner, B.A., Duffy, L.K. and Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides, Science, 250 (1990) 279-282.